Current Liabilities
Accounts Payable
Pfizer Accounts Payable increased by 825.8% to $5.24B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 7.0%, from $5.63B to $5.24B. Over 5 years (FY 2020 to FY 2025), Accounts Payable shows an upward trend with a 4.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
An increase can indicate better credit terms or increased production volume, while a decrease might suggest faster payments or reduced purchasing.
Detailed definition
The amount of money a company owes to its suppliers and vendors for goods and services purchased on credit. In a large-s...
Peer comparison
Companies with significant supply chain leverage often maintain high payables to maximize their own cash-on-hand.
Metric ID:
accounts_payableHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.33B | $4.70B | $5.58B | $5.51B | $6.21B | $6.27B | $6.81B | $6.12B | $779.00M | $781.00M | $6.71B | $658.00M | $593.00M | $628.00M | $5.63B | $546.00M | $501.00M | $566.00M | $5.24B |
| QoQ Change | — | +8.6% | +18.7% | -1.3% | +12.7% | +1.0% | +8.6% | -10.1% | -87.3% | +0.3% | +759.2% | -90.2% | -9.9% | +5.9% | +797.0% | -90.3% | -8.2% | +13.0% | +825.8% |
| YoY Change | — | — | — | — | +43.5% | +33.4% | +22.1% | +11.2% | -87.5% | -87.5% | -1.5% | -89.3% | -23.9% | -19.6% | -16.1% | -17.0% | -15.5% | -9.9% | -7.0% |
Range$501.00M – $6.81B
CAGR+4.3%
Avg YoY Growth-17.6%
Median YoY Growth-15.5%
Current Streak2 quarters growth
Accounts Payable at Other Companies
Frequently Asked Questions
- What is Pfizer's accounts payable?
- Pfizer (PFE) reported accounts payable of $5.24B in Q4 2025.
- How has Pfizer's accounts payable changed year-over-year?
- Pfizer's accounts payable decreased by 7.0% year-over-year, from $5.63B to $5.24B.
- What is the long-term trend for Pfizer's accounts payable?
- Over 5 years (2020 to 2025), Pfizer's accounts payable has grown at a 4.0% compound annual growth rate (CAGR), from $4.31B to $5.24B.
- What does accounts payable mean?
- The total amount of money the company owes to its suppliers for items it has already received.